E-LIB Suche - Ergebnisse für: Kerem, E

1

ECFS standards of care on CFTR-related disorders: Towards a..:

De Wachter, E ; De Boeck, K ; Sermet-Gaudelus, I...
Journal of Cystic Fibrosis. 23 (2024) 3 - p. 388-397 , 2024

Link: https://doi.org/10.1016/..

2

WS06.02 First-in-human clinical trial with SPL84, an ASO fo..:

Kerem, E. ; Caraco, Y. ; Wanounou, M....
Journal of Cystic Fibrosis. 23 (2024) - p. S11 , 2024

Link: https://doi.org/10.1016/..

3

WS02.01 Health inequality in Europe in cystic fibrosis peop..:

Sermet-Gaudelus, I. ; Orenti, A.L. ; Hatziagorou, E....
Journal of Cystic Fibrosis. 23 (2024) - p. S3 , 2024

Link: https://doi.org/10.1016/..

4

WS06.06 Safety and efficacy of a nebulized phage cocktail i..:

Kerem, E. ; Rappo, U. ; Cohen, A....
Journal of Cystic Fibrosis. 23 (2024) - p. S12 , 2024

Link: https://doi.org/10.1016/..

5

WS06.05 Long-term outcomes in people with CF lacking early ..:

Hadhud, M. ; Reiter, J. ; Meir, E. Ben...
Journal of Cystic Fibrosis. 23 (2024) - p. S12 , 2024

Link: https://doi.org/10.1016/..

6

EPS6.01 Improved outcome in the adult cystic fibrosis popul..:

Orenti, A. ; Hatziagorou, E. ; Kerem, E...
Journal of Cystic Fibrosis. 23 (2024) - p. S50 , 2024

Link: https://doi.org/10.1016/..

7

P052 Efficacy of elexacaftor/tezacaftor/ivacaftor in people..:

Yaacoby-Bianu, K. ; Dagan, A. ; Cohen-Cymberknoh, M....
Journal of Cystic Fibrosis. 22 (2023) - p. S79 , 2023

Link: https://doi.org/10.1016/..

8

116 First-in-human clinical trial with SPL84, an antisense ..:

Caraco, Y. ; Wanounou, M. ; Friedman, L....
Journal of Cystic Fibrosis. 22 (2023) - p. S61 , 2023

Link: https://doi.org/10.1016/..

9

WS03.01 Differences in disease severity among different res..:

Mei-Zahav, M. ; Orenti, A. ; Jung, A...
Journal of Cystic Fibrosis. 22 (2023) - p. S5-S6 , 2023

Link: https://doi.org/10.1016/..

10

WS09.01 Extending the success of Trikafta to rare mutations..:

Stanleigh, N. ; Gur, M. ; Kerem, E...
Journal of Cystic Fibrosis. 22 (2023) - p. S18 , 2023

Link: https://doi.org/10.1016/..

11

P077 Clinical and functional efficacy of elexacaftor/tezaca..:

Cohen-Cymberknoh, M. ; Sadras, I. ; Kerem, E....
Journal of Cystic Fibrosis. 22 (2023) - p. S87 , 2023

Link: https://doi.org/10.1016/..

12

290 Extending the success of elexacaftor-tezacaftor-ivacaft..:

Kerem, B. ; Stanleigh, N. ; Gur, M...
Journal of Cystic Fibrosis. 22 (2023) - p. S146 , 2023

Link: https://doi.org/10.1016/..

13

P095 A phase 1b/2a randomized, double-blind, placebo-contro..:

Rappo, U. ; Kahan-Hanum, M. ; Ussery, X....
Journal of Cystic Fibrosis. 22 (2023) - p. S93 , 2023

Link: https://doi.org/10.1016/..

14

126 A phase 1b/2a randomized, double-blind, placebo-control..:

Rappo, U. ; Kahan-Hanum, M. ; Ussery, X....
Journal of Cystic Fibrosis. 22 (2023) - p. S66-S67 , 2023

Link: https://doi.org/10.1016/..

15

P088 Ventilation inhomogeneity in patients with cystic fibr..:

Breuer, O. ; Akvian, I. ; Gartner, S....
Journal of Cystic Fibrosis. 21 (2022) - p. S87 , 2022

Link: https://doi.org/10.1016/..